RECRUITMENT IN ONTARIO IS NOW OPEN

Research on medications that reduce symptoms faster and prevent long COVID.

Research on medications that reduce symptoms faster and prevent long COVID.

The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days.

About the study

Our goal is to identify effective, safe, affordable, and evidence-based medications so they can be accessed by the community

Reduce hospitalizations, reduce the burden on hospitals and ICUs, and help people have fewer symptoms and feel better faster

Open to Canadian residents (18+ years of age) who are within the first 5 days of experiencing COVID-19 symptoms

Directly influence standards of care for COVID-19 infection in community settings in Canada and around the world

Supported by $10 million in grants from the Canadian Institutes of Health Research, Health Canada and Public Health Agency of Canada

30+ partner organizations engaging diverse populations across Canada to evaluate the clinical- and cost-effectiveness of  medications for COVID-19

Participate in our study.

Participate in our study

The CanTreatCOVID trial relies on volunteers, often referred to as participants, to help us better understand the effectiveness of medications for mild to moderate COVID-19. The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days.

Subscribe to our newsletter

Sign up for our newsletter to keep on top of the latest CanTreatCOVID study updates and become part of our community.